Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Strides Fast-Tracks China Entry With Joint Venture

Executive Summary

India’s Strides has announced its entry into China through a joint-venture with one of the country’s leading pharmaceutical firms, Sihuan, at the same time as reporting first-quarter EBITDA that soared by 155%.

You may also be interested in...



Strides Grows In Central Europe Through Fairmed Deal

Strides Pharma Science has acquired a majority stake in Swiss generics firm Fairmed Healthcare in a move to bolster its presence in central Europe. The acquisition marks the latest in a string of transactions by the Indian firm.

Strides Buys Florida Soft-Gel Capsule Facility To Support US Growth Plans

India's Strides has bought a Florida soft-gel capsule manufacturing plant for $500,000 and plans to pump in up to $10m in investment to build capacity and add dosage formats.

Newly-Formed Arrotex Is Considering Further Deals

Following the formation of Australia’s Arrotex through the merger of Apotex Australia and former Strides unit Arrow Pharmaceuticals, CEO Dennis Bastas sets out the firm’s priorities as a central player in the Australian market, as well as longer-term plans including potential future deals and reaching beyond Australia and into south-east Asia, in an exclusive interview with Generics Bulletin.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

GB140559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel